Skip to main content

Andera Partners

13F filer · CIK 0001757283
Reported Jul 22, 2026
Net buyer this quarter
13F portfolio value$206MU.S. long equity reported on 13F
Positions81 new · 0 closed
Net flow last quarter+$31.6MBuys minus sells
Top 10 positions weight100.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Jul 22, 20268 positions
KMTSKestra Medical Technologies, Ltd.$69.4M33.62%4.67%+1.2%Q4 2025
MLYSMineralys Therapeutics, Inc.$42.9M20.80%1.80%Not reportedQ4 2025
AVLNAvalyn Pharma Inc.$30.6M14.82%2.10%NewQ2 2026
AGMBAgomab Therapeutics NV$20M9.67%4.50%Not reportedQ1 2026
EVMNEvommune, Inc.$18.5M8.96%3.84%-26.6%Q4 2025
IVAInventiva S.A.$13.7M6.65%1.88%+99.8%Q4 2025
ABVXAbivax S.A.$10.4M5.04%0.10%Not reportedQ4 2025
NYXHNyxoah SA$882K0.43%1.21%Not reportedQ1 2026
Q1 2026Reported May 11, 20267 positions
KMTSKestra Medical Technologies, Ltd.$53.7M30.36%4.62%+6.1%Q4 2025
EVMNEvommune, Inc.$43.6M24.66%5.27%Not reportedQ4 2025
MLYSMineralys Therapeutics, Inc.$43.1M24.38%1.93%Not reportedQ4 2025
AGMBAgomab Therapeutics NV$16.1M9.12%4.50%NewQ1 2026
IVAInventiva S.A.$10.1M5.70%0.94%Not reportedQ4 2025
ABVXAbivax S.A.$8.7M4.92%0.10%Not reportedQ4 2025
NYXHNyxoah SA$1.52M0.86%1.21%NewQ1 2026
Q4 2025Reported Feb 17, 20265 positions
KMTSKestra Medical Technologies, Ltd.$67.4M38.14%4.35%NewQ4 2025
MLYSMineralys Therapeutics, Inc.$57.8M32.71%1.95%NewQ4 2025
EVMNEvommune, Inc.$32.5M18.39%6.02%NewQ4 2025
ABVXAbivax S.A.$10.5M5.97%0.10%NewQ4 2025
IVAInventiva S.A.$8.45M4.79%0.94%NewQ4 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.